These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12604039)

  • 21. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
    J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative.
    Kono K; Igawa T; Takagishi T
    Biochim Biophys Acta; 1997 Apr; 1325(2):143-54. PubMed ID: 9168140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid.
    Yang ST; Zaitseva E; Chernomordik LV; Melikov K
    Biophys J; 2010 Oct; 99(8):2525-33. PubMed ID: 20959093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusogenic activity of PEGylated pH-sensitive liposomes.
    Vanić Z; Barnert S; Süss R; Schubert R
    J Liposome Res; 2012 Jun; 22(2):148-57. PubMed ID: 22149717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional reconstitution of influenza virus envelopes.
    Stegmann T; Morselt HW; Booy FP; van Breemen JF; Scherphof G; Wilschut J
    EMBO J; 1987 Sep; 6(9):2651-9. PubMed ID: 3678202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion of influenza virus particles with liposomes: requirement for cholesterol and virus receptors to allow fusion with and lysis of neutral but not of negatively charged liposomes.
    Nussbaum O; Rott R; Loyter A
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2831-7. PubMed ID: 1431810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes.
    Sigot V; Arndt-Jovin DJ; Jovin TM
    Bioconjug Chem; 2010 Aug; 21(8):1465-72. PubMed ID: 20715851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.
    Obata Y; Tajima S; Takeoka S
    J Control Release; 2010 Mar; 142(2):267-76. PubMed ID: 19861141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endosomal escape by photo-activated fusion of liposomes containing a malachite green derivative: a novel class of photoresponsive liposomes for drug delivery vehicles.
    Hayashi K; Watanabe M; Iwasaki T; Shudou M; Uda RM
    Photochem Photobiol Sci; 2019 Jun; 18(6):1471-1478. PubMed ID: 30964475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel pH-sensitive liposome formulation containing oleyl alcohol.
    Sudimack JJ; Guo W; Tjarks W; Lee RJ
    Biochim Biophys Acta; 2002 Aug; 1564(1):31-7. PubMed ID: 12100993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elastase activated liposomal delivery to nucleated cells.
    Pak CC; Erukulla RK; Ahl PL; Janoff AS; Meers P
    Biochim Biophys Acta; 1999 Jul; 1419(2):111-26. PubMed ID: 10407064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins.
    Cho JE; Kim HS; Ahn WS; Park YS
    J Microencapsul; 2001; 18(4):421-31. PubMed ID: 11428672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.
    Arkema A; Huckriede A; Schoen P; Wilschut J; Daemen T
    Vaccine; 2000 Jan; 18(14):1327-33. PubMed ID: 10618529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the formulation of pH-sensitive liposomes with long circulation times.
    Simões S; Moreira JN; Fonseca C; Düzgüneş N; de Lima MC
    Adv Drug Deliv Rev; 2004 Apr; 56(7):947-65. PubMed ID: 15066754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery.
    Mo R; Jiang T; Gu Z
    Angew Chem Int Ed Engl; 2014 Jun; 53(23):5815-20. PubMed ID: 24764317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modular drug transporters with diphtheria toxin translocation domain form edged holes in lipid membranes.
    Khramtsov YV; Rokitskaya TI; Rosenkranz AA; Trusov GA; Gnuchev NV; Antonenko YN; Sobolev AS
    J Control Release; 2008 Jun; 128(3):241-7. PubMed ID: 18442865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.